Immunosuppression in Pediatric Kidney Transplant Patients.
10.4285/jkstn.2015.29.1.1
- Author:
Sang Il MIN
1
;
Ahram HAN
;
Chanjoong CHOI
;
Song Yi KIM
;
Hee Gyung KANG
;
Il Soo HA
;
Jongwon HA
Author Information
1. Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. jwhamd@snu.ac.kr
- Publication Type:Review
- Keywords:
Kidney transplantation;
Immunosuppression;
Child
- MeSH:
Allografts;
Child;
Humans;
Immunosuppression*;
Immunosuppressive Agents;
Kidney Transplantation;
Kidney*;
Organ Transplantation;
Transplants
- From:The Journal of the Korean Society for Transplantation
2015;29(1):1-8
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Over the last two decades, newer immunosuppressive agents have been introduced in the field of solid organ transplantation, and provided better graft and patient outcome. A wider range of immunosuppressants available to transplant physicians have resulted in improved therapeutic strategies to offer the combinations of medications with non-overlapping toxicities and more suitable immunosuppression. However, only a few clinical trials of new immunosuppressants have been conducted in pediatric patients. This review will discuss the cutting-edge strategy of immunosuppression in children and the current status of new immunosuppressive agents in pre- and post-transplant management to prevent kidney allograft rejection.
